PortfoliosLab logoPortfoliosLab logo
Scilex Holding Company (SCLXW)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date
Mar 8, 2021

Highlights

Market Cap
$1.28M
Enterprise Value
$122.58M
EPS (TTM)
-$32.40
Total Revenue (TTM)
$40.36M
Gross Profit (TTM)
$27.68M
EBITDA (TTM)
-$322.10M
Year Range
$0.04 - $0.65
ROA (TTM)
-136.23%
ROE (TTM)
212.41%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Scilex Holding Company

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Scilex Holding Company, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Scilex Holding Company (SCLXW) has returned 16.02% so far this year and 9.99% over the past 12 months.


Scilex Holding Company

1D
-15.31%
1M
-26.31%
YTD
16.02%
6M
-54.14%
1Y
9.99%
3Y*
-52.84%
5Y*
-24.54%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Mar 8, 2021, SCLXW's average daily return is +0.67%, while the average monthly return is +13.80%. At this rate, your investment would double in approximately 0.4 years.

Historically, 44% of months were positive and 56% were negative. The best month was Jan 2023 with a return of +657.0%, while the worst month was Aug 2023 at -66.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 4 months.

On a daily basis, SCLXW closed higher 41% of trading days. The best single day was Nov 22, 2022 with a return of +117.3%, while the worst single day was Nov 15, 2024 at -47.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202647.52%6.71%-26.31%16.02%
2025-4.76%-57.95%19.02%8.79%-14.60%12.47%430.50%-17.10%-47.80%4.12%-20.24%-52.41%-54.81%
202436.81%-8.65%-18.66%-26.90%-0.64%69.26%-17.52%-6.74%-36.41%32.27%0.38%-28.13%-41.67%
2023657.01%-13.29%-15.32%59.05%-15.56%-1.43%17.27%-66.26%-9.09%25.98%-39.66%-5.29%90.58%
2022-43.33%9.80%15.34%-7.45%-23.05%-35.00%0.33%40.00%-18.95%-3.17%82.16%-37.08%-58.02%
2021-24.40%13.64%5.98%1.72%15.03%-20.97%2.04%12.00%0.39%-19.96%-22.68%

Benchmark Metrics

Scilex Holding Company has an annualized alpha of 418.37%, beta of 0.36, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 09, 2021.

  • This stock participated in 241.66% of S&P 500 Index downside but only 237.09% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.36 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
418.37%
Beta
0.36
0.00
Upside Capture
237.09%
Downside Capture
241.66%

Return for Risk

Risk / Return Rank

SCLXW ranks 56 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


SCLXW Risk / Return Rank: 5656
Overall Rank
SCLXW Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
SCLXW Sortino Ratio Rank: 7878
Sortino Ratio Rank
SCLXW Omega Ratio Rank: 7474
Omega Ratio Rank
SCLXW Calmar Ratio Rank: 4444
Calmar Ratio Rank
SCLXW Martin Ratio Rank: 4242
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Scilex Holding Company (SCLXW) and compare them to a chosen benchmark (S&P 500 Index).


SCLXWBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.04

0.90

-0.85

Sortino ratio

Return per unit of downside risk

2.01

1.39

+0.62

Omega ratio

Gain probability vs. loss probability

1.25

1.21

+0.04

Calmar ratio

Return relative to maximum drawdown

0.12

1.40

-1.28

Martin ratio

Return relative to average drawdown

0.18

6.61

-6.43

Explore SCLXW risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Scilex Holding Company doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Scilex Holding Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Scilex Holding Company was 98.57%, occurring on Apr 17, 2025. The portfolio has not yet recovered.

The current Scilex Holding Company drawdown is 96.86%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.57%Apr 13, 2023506Apr 17, 2025
-82.21%Nov 18, 2021253Nov 18, 202237Jan 13, 2023290
-59.41%Feb 9, 202333Mar 28, 20237Apr 6, 202340
-42.06%Mar 15, 202110Mar 26, 2021164Nov 17, 2021174
-36.78%Jan 23, 20232Jan 24, 202310Feb 7, 202312

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Scilex Holding Company over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Scilex Holding Company is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for SCLXW relative to other companies in the Drug Manufacturers - General industry. Currently, SCLXW has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items